Supernus Pharmaceuticals Inc (SUPN)
29.56
-0.70
(-2.31%)
USD |
NASDAQ |
Apr 25, 13:22
Supernus Pharmaceuticals Free Cash Flow (Quarterly): 44.99M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.99M |
| September 30, 2023 | 35.72M |
| June 30, 2023 | -19.03M |
| March 31, 2023 | 48.85M |
| December 31, 2022 | 27.57M |
| September 30, 2022 | 13.69M |
| June 30, 2022 | 71.70M |
| March 31, 2022 | 3.451M |
| December 31, 2021 | 48.72M |
| September 30, 2021 | -4.154M |
| June 30, 2021 | 46.27M |
| March 31, 2021 | 34.24M |
| December 31, 2020 | 31.62M |
| September 30, 2020 | 5.296M |
| June 30, 2020 | 91.42M |
| March 31, 2020 | 6.379M |
| December 31, 2019 | 43.11M |
| September 30, 2019 | 37.20M |
| June 30, 2019 | 28.66M |
| March 31, 2019 | 32.77M |
| December 31, 2018 | 32.75M |
| September 30, 2018 | 62.26M |
| June 30, 2018 | 6.252M |
| March 31, 2018 | 26.88M |
| December 31, 2017 | 35.58M |
| Date | Value |
|---|---|
| September 30, 2017 | 38.58M |
| June 30, 2017 | 25.39M |
| March 31, 2017 | 13.06M |
| December 31, 2016 | 24.64M |
| September 30, 2016 | 27.84M |
| June 30, 2016 | 16.15M |
| March 31, 2016 | -3.421M |
| December 31, 2015 | 19.06M |
| September 30, 2015 | 1.422M |
| June 30, 2015 | 12.39M |
| March 31, 2015 | -0.454M |
| December 31, 2014 | 6.145M |
| September 30, 2014 | -4.808M |
| June 30, 2014 | -7.058M |
| March 31, 2014 | -19.37M |
| December 31, 2013 | -9.347M |
| September 30, 2013 | -16.23M |
| June 30, 2013 | -16.42M |
| March 31, 2013 | -17.60M |
| December 31, 2012 | -16.34M |
| September 30, 2012 | -11.70M |
| June 30, 2012 | -9.809M |
| March 31, 2012 | -10.11M |
| December 31, 2011 | -8.449M |
| September 30, 2011 | -9.18M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.03M
Minimum
Jun 2023
91.42M
Maximum
Jun 2020
31.35M
Average
34.24M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| Dynavax Technologies Corp | 12.04M |
| Ligand Pharmaceuticals Inc | -42.68M |
| Pacira BioSciences Inc | 45.79M |
| Esperion Therapeutics Inc | -37.06M |
| Collegium Pharmaceutical Inc | 73.17M |